Cohort plc (LON:CHRT - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 832.19 ($10.83) and traded as high as GBX 934 ($12.16). Cohort shares last traded at GBX 896 ($11.66), with a volume of 473,087 shares trading hands.
Analysts Set New Price Targets
Separately, Shore Capital restated a "buy" rating on shares of Cohort in a report on Tuesday, September 24th.
Check Out Our Latest Report on CHRT
Cohort Stock Performance
The stock has a market cap of £373.67 million, a P/E ratio of 2,431.58 and a beta of 0.56. The company has a debt-to-equity ratio of 36.88, a current ratio of 1.55 and a quick ratio of 0.93. The stock's 50 day simple moving average is GBX 874.69 and its two-hundred day simple moving average is GBX 832.19.
Insider Activity at Cohort
In other news, insider Simon Walther acquired 598 shares of the firm's stock in a transaction that occurred on Friday, October 4th. The stock was acquired at an average cost of GBX 906 ($11.79) per share, for a total transaction of £5,417.88 ($7,052.69). 39.22% of the stock is currently owned by insiders.
About Cohort
(
Get Free Report)
Cohort plc, through its subsidiaries, provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and the Asia Pacific and Africa. The company offers electro-optical and electro-mechanical systems, such as command, control, communications, computers, intelligence, surveillance, target acquisition, and reconnaissance, as well as combat systems; and communications systems.
Featured Articles
Before you consider Cohort, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cohort wasn't on the list.
While Cohort currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
